Literature DB >> 9737544

Cell death mechanisms in multiple system atrophy.

S Probst-Cousin1, C H Rickert, K W Schmid, F Gullotta.   

Abstract

The presence and distribution of apoptotic cell death in multiple system atrophy (MSA) and morphologically related diseases were investigated by means of a modified terminal deoxynucleotidyl transferase-mediated nick end labeling method, comparing their distribution with that of glial cytoplasmic inclusions, immunohistochemically demonstrated bcl-2 protein, bax protein, CD95, TNFalpha, and p53-protein expression, as well as activated microglia. Apoptosis occurred almost exclusively in oligodendrocytes in multiple system atrophy and its general distribution was comparable to the already known oligodendroglial pathology in this disorder. Additionally, in about a quarter of glial cytoplasmic inclusions, there was upregulation of bcl-2-protein and coexpression with ubiquitin, suggesting a final attempt of involved cells to counteract apoptotic cell death. Bax protein was also demonstrated in oligodendroglial cells. A significant neuronal apoptosis was not observed in MSA; these cells might be destroyed secondarily to oligodendroglial apoptosis by necrosis or other forms of programmed cell death. These results emphasize the central role of oligodendroglial pathology in multiple system atrophy, making this disease unique among neurodegenerative diseases.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9737544     DOI: 10.1097/00005072-199809000-00002

Source DB:  PubMed          Journal:  J Neuropathol Exp Neurol        ISSN: 0022-3069            Impact factor:   3.685


  15 in total

1.  Myeloperoxidase inhibition ameliorates multiple system atrophy-like degeneration in a transgenic mouse model.

Authors:  Nadia Stefanova; Biljana Georgievska; Håkan Eriksson; Werner Poewe; Gregor K Wenning
Journal:  Neurotox Res       Date:  2011-12-08       Impact factor: 3.911

2.  Neuronal apoptosis following human brain injury.

Authors:  R Hausmann; T Biermann; I Wiest; J Tübel; P Betz
Journal:  Int J Legal Med       Date:  2003-11-18       Impact factor: 2.686

3.  Neurodegeneration in a transgenic mouse model of multiple system atrophy is associated with altered expression of oligodendroglial-derived neurotrophic factors.

Authors:  Kiren Ubhi; Edward Rockenstein; Michael Mante; Chandra Inglis; Anthony Adame; Christina Patrick; Kristen Whitney; Eliezer Masliah
Journal:  J Neurosci       Date:  2010-05-05       Impact factor: 6.167

Review 4.  Multiple system atrophy: cellular and molecular pathology.

Authors:  D J Burn; E Jaros
Journal:  Mol Pathol       Date:  2001-12

5.  Oxidative stress in transgenic mice with oligodendroglial alpha-synuclein overexpression replicates the characteristic neuropathology of multiple system atrophy.

Authors:  Nadia Stefanova; Markus Reindl; Manuela Neumann; Christian Haass; Werner Poewe; Philipp J Kahle; Gregor K Wenning
Journal:  Am J Pathol       Date:  2005-03       Impact factor: 4.307

Review 6.  Recent developments in multiple system atrophy.

Authors:  Gregor K Wenning; Nadia Stefanova
Journal:  J Neurol       Date:  2009-05-27       Impact factor: 4.849

7.  Heterogeneous intrastriatal pattern of proteins regulating axon growth in normal adult human brain.

Authors:  Junchao Tong; Yoshiaki Furukawa; Allan Sherwin; Oleh Hornykiewicz; Stephen J Kish
Journal:  Neurobiol Dis       Date:  2010-10-26       Impact factor: 5.996

Review 8.  Imaging of neuroinflammation in parkinsonian syndromes with positron emission tomography.

Authors:  Alexander Gerhard
Journal:  Curr Neurol Neurosci Rep       Date:  2013-12       Impact factor: 5.081

9.  Neuroglia in the inferior olivary nucleus during normal aging and Alzheimer's disease.

Authors:  H Lasn; B Winblad; N Bogdanovic
Journal:  J Cell Mol Med       Date:  2006 Jan-Mar       Impact factor: 5.310

Review 10.  Towards translational therapies for multiple system atrophy.

Authors:  Daniela Kuzdas-Wood; Nadia Stefanova; Kurt A Jellinger; Klaus Seppi; Michael G Schlossmacher; Werner Poewe; Gregor K Wenning
Journal:  Prog Neurobiol       Date:  2014-03-02       Impact factor: 11.685

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.